Laos vs Slovenia: Cause of death, by non-communicable diseases, ages 60+, male
Laos
77.2%
in 2021
Slovenia
77.2%
in 2021
Laos rank
60th
Slovenia rank
61st
Cause of death, by non-communicable diseases, ages 60+, male over time
- Laos
- Slovenia
How they compare
Laos currently reports 77.2% against 77.2% in Slovenia, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Slovenia ahead.
Laos ranks 60th and Slovenia ranks 61st of 185 countries.
Across the 3 decades both report, Laos averaged higher in 1 and Slovenia in 2.
Head to head by decade
| Decade | Laos | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.6% | 89.8% | 16.2% | Slovenia |
| 2010s | 81.4% | 90.6% | 9.1% | Slovenia |
| 2020s | 81.1% | 77.0% | 4.2% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Laos or Slovenia?
- Laos, at 77.2% against 77.2% in Slovenia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Laos and Slovenia?
- 0.0%, with Laos ahead.
- How many years of comparable data are there for Laos and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Laos and Slovenia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Laos ranks 60th and Slovenia ranks 61st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.